Atlas Trials

Phase I: Relapsed or Refractory B-cell Malignancies

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Phase I: Relapsed or Refractory B-cell Malignancies

RecordFirmDate
Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell Malignancies (NCT03932331)AstraZeneca2020-04-29

Track Phase I: Relapsed or Refractory B-cell Malignancies automatically

Every clearance here is in the API, with alerts when new ones post.